Skip to main content
. 2022 Mar 14;7(11):9867–9878. doi: 10.1021/acsomega.2c00288

Table 3. NBO Analysis of the Studied Compounds.

comp donor (i) type acceptor (j) type E(2)a[kcal/mol] E(J)E(i)b(a.u) F(I,j)c(a.u
MFIP C26–C28 π C30–C31 π* 23.1 0.30 0.074
  C8–C9 π C8–C9 π* 1.82 0.29 0.021
  C30–C31 σ C28–C30 σ* 5.96 1.30 0.079
  F2–C33 σ F3–C33 σ* 0.68 1.33 0.027
  O4 LP(2) C8–C9 π* 39.52 0.36 0.113
  F1 LP(1) C30–C33 σ* 0.52 1.49 0.025
FPIN C5–C20 π N4–C21 π* 26.35 0.29 0.08
  C5–C20 π C5–C20 π* 3.48 0.29 0.029
  C11–H12 σ C10–C19 σ* 5.20 1.08 0.067
  C15–H16 σ C13–C15 σ* 0.52 1.09 0.021
  O2 LP(2) C5–C20 π* 44.37 0.36 0.118
  O2 LP(1) C5–C6 σ* 0.73 1.14 0.026